JNJ Johnson & Johnson stock chart & analysis
Conviction 55HealthcareScan · Fri, Nov 6, 2026Johnson & Johnson (JNJ) closed at $276.22 (+1.43%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 59, RS Rating 92, -2.0% from its 52-week high, +33.5% year to date. Sector: Healthcare · Pharmaceutical Preparations.
Financials as of Sun, Sep 27, 2026 · quarterly.
JNJ technical analysis
Trend
JNJ is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 3.9% above the 50-day ($265.79) and 11.2% above the 200-day ($248.33). ADX(14) at 23 points to a moderate trend. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 59, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 92 puts its weighted 12-month performance ahead of about 92% of the US market, and its RS line is at a new high.
Volume and volatility
Volume on the latest session ran 1.1× its 20-day average. It trades about $2.1B a day on average. ATR(14) is $7.41, 2.7% of price — its typical daily range. Chaikin Money Flow (0.08) shows accumulation.
Key levels
The chart pattern's support is $248.17 and its resistance $278.62. The 52-week range is $185.12 to $282.02; price is 2.0% below the high and 49.2% above the low. The VWAP anchored at the 52-week high is $272.96, below price.
Performance
JNJ returned +1.1% (1 week), +7.7% (1 month), +5.5% (3 months), +24.8% (6 months), +48.5% (1 year), +33.5% (year to date).
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Pharmaceutical Preparations · Listed 1944 · 140,800 employees
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upAug 25 – Aug 315 scans
- Breaking out nowSep 11 scan
- Broke outSep 2 – Sep 32 scans
- Breaking out nowOct 221 scan
- Setting upOct 23 – Oct 262 scans
Congress activity
Disclosed STOCK Act trades in JNJ · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Thomas H. Kean house · R · NJ · traded 2026-09-30 | Sell | $1K–$15K | 2026-09-30 | 2026-10-30 | |
 Lloyd Doggett house · D · TX · traded 2026-09-08 | Buy | $1K–$15K | 2026-09-08 | 2026-10-05 | |
Thomas H. Kean house · R · NJ · traded 2026-08-27 | Sell | $1K–$15K | 2026-08-27 | 2026-09-12 | |
 John Boozman senate · R · AR · traded 2026-08-20 | Sell | $1K–$15K | 2026-08-20 | 2026-09-11 | |
 Richard Dean Dr McCormick house · R · GA · traded 2026-07-30 | Sell | $1K–$15K | 2026-07-30 | 2026-08-14 | |
 Thomas H Tuberville senate · traded 2024-10-29 | Sell | $15K–$50K | 2024-10-29 | 2026-08-05 | |
Thomas H Tuberville senate · traded 2024-10-29 | Sell | $15K–$50K | 2024-10-29 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-30 | Buy | $1K–$15K | 2026-03-30 | 2026-07-21 | |
Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $15K–$50K | 2026-03-27 | 2026-07-21 | |
Thomas H. Kean house · R · NJ · traded 2026-06-02 | Sell | $1K–$15K | 2026-06-02 | 2026-07-15 |
Insider activity
SEC Form 4 transactions in JNJ · open-market 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Taubert Jennifer L EVP, WWC. Innovative Medicine · Common Stock · 2026-08-17 | Sell | 15K | $4.0M | 2026-08-17 | 2026-08-18 |
Taubert Jennifer L EVP, WWC. Innovative Medicine · Common Stock · 2026-08-17 | Exercise | 15K | $1.7M | 2026-08-17 | 2026-08-18 |
Taubert Jennifer L EVP, WWC. Innovative Medicine · Employee Stock Options (Right to Buy) · 2026-08-17 | Exercise | 15K | — | 2026-08-17 | 2026-08-18 |
Duato Joaquin CEO and Chairman of the Board · Common Stock · 2026-08-13 | Sell | 102.31K | $27M | 2026-08-13 | 2026-08-14 |
Duato Joaquin CEO and Chairman of the Board · Employee Stock Options (Right to Buy) · 2026-08-13 | Exercise | 123.29K | — | 2026-08-13 | 2026-08-14 |
Duato Joaquin CEO and Chairman of the Board · Common Stock · 2026-08-13 | Exercise | 123.29K | $14M | 2026-08-13 | 2026-08-14 |
Duato Joaquin CEO and Chairman of the Board · Common Stock · 2026-08-13 | Sell | 20.98K | $5.5M | 2026-08-13 | 2026-08-14 |
Forminard Elizabeth EVP, Chief Legal Officer · Common Stock · 2026-08-06 | Exercise | 9.34K | $1.2M | 2026-08-06 | 2026-08-07 |
Forminard Elizabeth EVP, Chief Legal Officer · Common Stock · 2026-08-06 | Sell | 9.34K | $2.4M | 2026-08-06 | 2026-08-07 |
Forminard Elizabeth EVP, Chief Legal Officer · Common Stock · 2026-08-06 | Sell | 6.57K | $1.7M | 2026-08-06 | 2026-08-07 |
SEC filings
EDGAR filings in JNJ · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.